TWD
CTKB icon

True Wealth Design’s Cytek Biosciences CTKB Stock Holding History

True Wealth Design’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.43K Buy
576
+7
+1% +$33 ﹤0.01% 1480
2026
Q2 		$2.52K Sell
569
-142
-20% -$606 ﹤0.01% 1593
2026
Q1 		$3.11K Buy
711
+98
+16% +$463 ﹤0.01% 1386
2025
Q4 		$3.1K Sell
613
-204
-25% -$947 ﹤0.01% 1282
2025
Q3 		$2.83K Sell
817
-32
-4% -$120 ﹤0.01% 1338
2025
Q2 		$2.89K Sell
849
-314
-27% -$1.05K ﹤0.01% 1020
2025
Q1 		$4.66K Buy
+1,163
New +$6.03K ﹤0.01% 709

Other funds holding CTKB

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
DCM
Davis Capital Management Jacksonville, Florida $167M AUM 17.17% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return

True Wealth Design's CTKB Position: Q3 2026 in Review

True Wealth Design increased its Cytek Biosciences (CTKB) stake by 1.2% in Q3 2026, buying an estimated $33 and bringing the position to 576 shares worth $3.43K. The position accounts for ﹤0.01% of the portfolio, ranked #1480.

True Wealth Design first reported a position in CTKB in Q1 2025 and has held it in 7 quarters since. The position peaked at $4.66K in Q1 2025. 9 funds tracked by Wall St. Rank hold CTKB as of Q3 2026.

  • True Wealth Design held 576 shares of Cytek Biosciences worth $3.43K as of Q3 2026.
  • True Wealth Design bought 7 Cytek Biosciences shares in Q3 2026, an estimated $33.
  • Cytek Biosciences made up ﹤0.01% of True Wealth Design's portfolio in Q3 2026, its #1480 holding.
  • True Wealth Design first reported a position in Cytek Biosciences in Q1 2025 and has held it in 7 quarters since.
  • True Wealth Design's Cytek Biosciences position peaked at $4.66K in Q1 2025.
  • 9 funds tracked by Wall St. Rank held Cytek Biosciences as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.